Hispidin, extracted from the wild mushroom, shows anti-neoplastic properties, non-toxicity, and potential as a bone cancer inhibitor. Identified and characterized using spectroscopic and computational techniques. Good inhibitor for bone cancer targets.
Researchers tested ethyl acetate extract of a plant against breast cancer cells, showing selective and promising anticancer activity. This natural compound may be developed as an effective treatment for breast cancer.
Limonin, a common ingredient in citrus fruits, shows potential for antitumor effects on colorectal cancer cells and cancer stem-like cells, which could improve outcomes for patients with CRC.
Study demonstrates Ganoderma lucidum extracts inhibit endometrial cancer by activating Rap1 signaling pathway, inhibiting proliferation, promoting apoptosis, and blocking cell cycle. Important for potential cancer treatment research.
POL in TCM treats inflammation and tumors in the digestive system. Its diverse compounds have strong anti-inflammatory and anti-cancer effects. Important for potential medical advancements.
Study assessed Hedyotis diffusa Willd effects on CRC using network pharmacology & experimental validation. Identified potential targets, key genes, pathways, & validated anti-CRC effects in vitro. Important for developing new CRC treatments.
Artemisia argyi can help overcome lapatinib resistance in HER2-positive breast cancer by activating TMPRSS2, leading to cell death and potentially improving therapy outcomes.
RN0D from Panax notoginseng induces mitochondrial dysfunction in cancer cells, leading to cell death through ATP deprivation and mitophagy. Targets Galectin-3 and activates PINK1/Parkin pathway, showing promise as an anticancer therapeutic.